EcoDrugPlus

Trace Amine Associated Receptor 1

Ensembl ID : ENSMMDG00005010581
Gene Symbol: TAAR1
1 Cross references
620 Possible Orthologues:

Transcription Factor P65-Like

Ensembl ID : ENSMMDG00005010771
Gene Symbol: LOC115376764
3 Cross references
199 Possible Orthologues:

Transforming Growth Factor, Beta Receptor 1 B

Ensembl ID : ENSMMDG00005002509
Gene Symbol: TGFBR1B
1 Cross references
204 Possible Orthologues:

Transient Receptor Potential Cation Channel, Subfamily A, Member 1b

Ensembl ID : ENSMMDG00005015475
Gene Symbol: TRPA1B
1 Cross references
200 Possible Orthologues:

Transthyretin (Prealbumin, Amyloidosis Type I)

Ensembl ID : ENSMMDG00005003273
Gene Symbol: TTR
1 Cross references
178 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSMMDG00005020216
Gene Symbol: TPH1
3 Cross references
207 Possible Orthologues:

Tryptophan Hydroxylase 1b

Ensembl ID : ENSMMDG00005002235
Gene Symbol: TPH1B
1 Cross references
176 Possible Orthologues:

Tubulin Alpha-1b Chain-Like

Ensembl ID : ENSMMDG00005004169
Gene Symbol: LOC115364266
2 Cross references
80 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSMMDG00005010661
Gene Symbol: TUBB1
3 Cross references
184 Possible Orthologues:

Tubulin Beta-2a Chain

Ensembl ID : ENSMMDG00005021687
Gene Symbol: LOC115375602
3 Cross references
305 Possible Orthologues:

Tubulin, Alpha 8 Like 2

Ensembl ID : ENSMMDG00005023841
Gene Symbol: TUBA8L2
1 Cross references
130 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSMMDG00005023193
Gene Symbol: TP53
2 Cross references
232 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).